肺癌是目前人类因癌症死亡的主要原因。但临床上约８６％的肺癌患者确认时已属晚期，失去手术及放射治疗的机会，化疗成为最主要的治疗方法。现将我们于１９９２年１月至１９９７年８月应用ＩＴＰ与ＣＴＰ方案治疗晚期本病（ＮＳＣＬＣ）的近期疗效及毒副作用比较，报道如... Lung cancer is currently the leading cause of death from cancer in humans. However, about 86% of patients with lung cancer have been clinically advanced at the time of confirmation, and they have lost opportunities for surgery and radiation therapy. Chemotherapy has become the main treatment method. Now we compare the short-term efficacy and side effects of the ITP and CTP regimens for the treatment of advanced stage disease (NSCLC) from January 1992 to August 1997.